Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative Oncology Drug, Eftilagimod Alfa
-
Abundia Global Impact Group, Inc. Initiates Trading Under New Ticker Symbol “AGIG”
-
Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy
-
FutureFuel Announces Director and Chairman of the Board Appointment
-
SPX Technologies to Acquire Crawford United
-
EBZT Announces Sports Edge AI Development for Polymarket Sports Prediction Markets
-
Rocket Doctor AI, Health Cities and CAN Health Network Partner to Advance AI-Powered Clinical Decision Support in Alberta
-
Fate Therapeutics Presents Updated Phase 1 Clinical Data of FT819 Off-the-shelf CAR T-cell Product Candidate for Systemic Lupus Erythematosus and Preclinical Advances in Next-Generation Off-the-Shelf
-
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogene
-
ReserveOne Announces Filing of Registration Statement on Form S-4 with the SEC for Proposed Business Combination with M3-Brigade Acquisition V Corp.
-
nCino Announces Stock Repurchase Program
-
Solid Biosciences to Showcase Proprietary Next-Generation Capsid AAV-SLB101 and Cardiac Gene Therapy Pipeline at the 22nd Global CardioVascular Clinical Trialists (CVCT) Forum
-
Osisko Development Launches Fully-Funded 70,000-Meter Exploration Drilling Campaign Targeting New Discoveries at Cariboo Gold Project
-
BIO-key Answers the Call for Secure, Modern Authentication with New Passwordless Innovations at the 2025 Gartner® IAM Summit: North America
-
Soleo Health Appoints Jody Thompson as New Senior Vice President of Business Development, Rare Disease
-
Ascent Solar Technologies Announces Up To $5.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Clip Money Inc. Announces Expanded Partnership with Centennial Delivering Cash Management Solutions to 1600+ Retailers
-
CALIFORNIA BANCORP ANNOUNCES FIRST CASH DIVIDEND
-
SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management
-
4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Gabelli Launches Keeley Dividend ETF (KDVD)
-
Brazil Potash Achieved Major 2025 Milestones, Positions for Construction Advancement in 2026
-
How Fenstermaker Uses Handheld Lidar to Map Schools for 911 Safety and Response
-
Westwood Holdings Group, Inc. Recognized in Pensions & Investments’ Best Places to Work in Money Management
-
ASML reports transactions under its current share buyback program
-
Roche’s Columvi combination shows sustained survival benefit at three-year follow up of pivotal phase III STARGLO study
-
Total Return Securities Fund Announces Expiration of Rights Offering
-
Transcontinental Inc. enters into Agreement to Sell its Packaging Business
-
Bang & Olufsen A/S - Transactions in connection with share buyback programme to hedge the company’s share-based incentive programmes
-
Zelluna ASA: New share capital registered
-
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
-
ContextLogic to Acquire US Salt from Emerald Lake in $907.5 Million Transaction, Creating New Business Ownership Platform in Partnership with Abrams Capital and BC Partners Credit
-
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
-
Stock Yards Bancorp Announces Promotion of William Otten to Chief Credit Officer of the Company as William Dishman Sets Retirement Date
-
Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
-
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at
-
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
-
Onex Completes Final Realization of Ryan Specialty, Delivering Strong Investing Results
-
Digi Power X Appoints Chief Technology Officer
-
Gemini to Participate in Goldman Sachs 2025 Financial Services Conference
-
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy
-
Gray Announces Private Placement of $250 Million of Additional 9.625% Senior Secured Second Lien Notes due 2032
-
Dragonfly Energy Expands Marine OEM Footprint with World’s Largest Power Catamaran Manufacturer, World Cat
-
BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review
-
Bitcoin Munari Advances to Round 4 at $0.50 as ETF Accumulation Models Dominate Market Debate
-
1 billion financing empowers! EngineAI T800 comes out in a big way, accelerating industrialization process
-
REKT Announces Launch of the First Meme Token That Rewards Losing Trades
-
Drone Nerds Expands Technology Portfolio with New Creality Partnership
-
Kraig Biocraft Laboratories Secures Usage Rights to Strategic Government-Owned Mulberry Gardens to Support Major Spider Silk Production Expansion
-
Asante Gold Announces Intention to Dual List on ASX
